AFINITOR DISPERZ

Identification of Afinitor Disperz

No description

Google image searchProduct monograph

Active ingredient

everolimus, 3 MG

DIN: 02425653

Dosage form(s): TABLET FOR SUSPENSION

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 28-NOV-2014

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AH — Mammalian target of rapamycin (mTOR) kinase inhibitors (ATC, ATC/DDD)
• L04AH02 — EVEROLIMUS (ATC/DDD)

Reference brand drug: Afinitor

Pharmaceutical standard: MFR

External Links for Afinitor Disperz

Search on Google

• Afinitor Disperz side effects
• Afinitor Disperz dosage
• everolimus side effects
• everolimus dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find afinitor disperz photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.